- Watch the recording of the introduction / part 1 / part 2 / part 3
- See pictures and download PDFs of the presentations.
Registration from 08.45.
 |
Her Royal Highness Crown Princess Mette-Marit will be present at the opening. |
09.30 – Introduction
 |
Introduction by Conference Host Nadia Hasnaoui |
 |
Welcome to the Oslo Life Science Conference Rector of the University of Oslo, Ole Petter Ottersen |
09.45 – Part 1
Building excellence in science and innovation I
 |
Systems approaches to studying the immune response in infection research at the Francis Crick Institute Associate Research Director (Group Leader Development), the Francis Crick Institute, Anne O’Garra |
 |
New vaccines for a safer world Interim CEO, Coalition for Epidemic Preparedness Innovations (CEPI), John-Arne Røttingen |
 |
Future in personalised cancer therapy Director and Professor, Centre for Molecular Medicine Norway NCMM – Nordic EMBL Partnership University of Oslo, Kjetil Taskén |
 |
To build a culture for innovation Professor, Department of Biosciences, the University of Oslo and Centre for Immune Regulation, UiO/Oslo University Hospital, Inger Sandlie |
 |
Looking for health or looking for trouble? Addressing ethical issues to improve innovation Professor, NTNU Gjøvik and Professor II, Centre for Medical Ethics, University of Oslo, Bjørn Hofmann |
 |
The UiO:Life Science initiative: why is it important for Oslo University Hospital? Director of research, innovation and education, Oslo University Hospital, Erlend B. Smeland |
Building political initiatives for growth in life sciences
 |
Moving forward with an ecosystem approach Executive Director, Division for Innovation, the Research Council of Norway, Anne Kjersti Fahlvik |
11.10 Lunch
12.10 – Part 2
Building political initiatives for growth in life sciences continues
 |
A stronger Danish life science – advice to the government from industry and academia Member of the growth team for life science appointed by the Danish government, Head of Department at Rigshospitalet and Professor at the University of Copenhagen, Liselotte Højgaard |
 |
The government's strategies for enabling technologies State Secretary, Ministry of Education and Research, Bjørn Haugstad (PhD) |
 |
Ambitions for green growth in the Life Science City Governing Mayor, the City of Oslo, Raymond Johansen |
 |
Implementation of the Health&Care21 strategy State Secretary, Ministry of Health and Care Services, Anne Grethe Erlandsen |
Building convergence in research and education
 |
Student innovation against antibiotic resistance Students from the UiO iGEM-team 2016, Torleif Tollefsrud Gjølberg and Ragnhild Bugge |
 |
Fighting the superbugs – turning the tide of antimicrobial resistance Head of Unit for Genome Dynamics, Department of Microbiology, Oslo University Hospital, and Professor, Institute of Clinical Medicine, the University of Oslo, Tone Tønjum |
13.30 Coffee break
14.10 – Part 3
Building convergence in research and education continues
 |
The ZinChel technology – fighting the ticking time-bomb of antimicrobial resistance Professor, the School of Pharmacy, the University of Oslo, Pål Rongved |
14.20 Building excellence in science and innovation II
 |
Digitalization, data and life sciences – why is DNV GL involved in BIGMED? President and CEO, DNV GL, Remi Eriksen |
 |
MRC Technology and accelerating the discovery and development of novel cancer therapeutics: Keytruda and beyond Therapeutics Review Team Leader, MRC Technology, UK, Kerstin Papenfuss (PhD) |
 |
Diagnosis of early stages of pancreatic cancer Chief Commercial Officer, Immunovia, Laura Chirica (PhD) |
 |
Developing a urine test for bladder cancer Head of the Epigentics group, Oslo University Hospital, and Professor II, Department of Biosciences, UiO, Guro Lind |
 |
Tomorrow's innovation: Changing R&D model in Life Science |
15.30 – Closing keynote and closing remarks
 |
Building effective startup ecosystems Founder and CEO of CIC (Cambridge Innovation Center), Tim Rowe |
 |
Closing remarks |
